ArticleCardiovascular therapeutics2022

Advanced Glycation End Product Blocker Drugs Have a Great Potential to Prevent Diabetic Cardiomyopathy in an Animal Model of Diabetes Mellitus Type-2.

Amir Hossein Heydari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.